Could This Be Merck's Next Blockbuster Drug?
18/3 14:20
Earlier this month, Merck (NYSE: MRK) announced positive results from a clinical trial of its cholesterol-lowering drug candidate MK-0616....
18/3 14:20
Earlier this month, Merck (NYSE: MRK) announced positive results from a clinical trial of its cholesterol-lowering drug candidate MK-0616....